Professor Graham Richards has worked with spin-out companies since 1988, when he was involved in founding the University of Oxford's technology transfer company, Isis Innovation Ltd. He went on to be a director of Isis Innovation for 20 years. Graham founded his own spin-out company, Oxford Molecular Ltd, in 1989 and was heavily involved with running this company for 11 years, until it was sold in 2000. He has also been a director of Catalyst Biomedica Ltd and a chairman of IP2IPO Group Plc, which later became the publicly quoted IP Group Plc. He is now a senior non-executive director of that